Acute lung affection in an endurance-trained man under amiodarone medication
Patients undergoing treatment with amiodarone can develop severe pulmonary side effects. This effect, which is often highly underestimated, can lead to dyspnea, pneumonitis, and further fibrosis. A recent change in the labeling of amdiodarone by the American Food and Drug Administration (FDA) suppor...
Main Authors: | Saurbier, Bernward, Zissel, Gernot, Windisch, Wolfram, Walterspacher, Stephan, Sorichter, Stephan |
---|---|
Format: | Article |
Language: | deu |
Published: |
German Medical Science GMS Publishing House
2005-06-01
|
Series: | GMS German Medical Science |
Subjects: | |
Online Access: | http://www.egms.de/en/gms/2005-3/000021.shtml |
Similar Items
-
Early recognition of acute pneumonitis in amiodarone treatment
by: Rishi Vinod Lohiya, et al.
Published: (2018-01-01) -
Amiodarone-related Pneumonitis
by: Sheng-Nan Chang, et al.
Published: (2007-05-01) -
Amiodarone pulmonary toxicity: a report on two cases
by: Ahmed Zedan, et al.
Published: (2015-03-01) -
Amiodarone-induced thyrotoxicosis: state of the art
by: Elena A. Lebedeva, et al.
Published: (2017-10-01) -
Acute myopathy secondary to amiodarone-induced thyrotoxicosis
by: Dave Duggan, et al.
Published: (2021-12-01)